Transgene (TRNG)

Paris


Symbol		Exchange		Currency
TRNG	·	Paris	·	EUR	Real-time
0OCQ	·	London	·	EUR	Real-time

Currency in EUR

0.745

-0.005(-0.67%)

Closed·11:35:59

Fair Value

Unlock Value

Day's Range

0.743

0.760

52 wk Range

0.530

1.500

TRNG Income Statement

Assess the Transgene income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the TRNG net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

17.24

10.34

7.9

6.35

7.21

Total Revenues Growth

aa.aa

+80.08%

-40%

-23.63%

-19.58%

+13.49%

Cost Of Revenues

aa.aa

32.88

32.17

29.59

34.28

33.9

Gross Profit

aa.aa

-15.64

-21.82

-21.69

-27.93

-26.69

Gross Profit Growth

aa.aa

+11.98%

-39.5%

+0.62%

-28.76%

+4.44%

Gross Profit Margin %

aa.aa

-90.75%

-210.98%

-274.53%

-439.56%

-370.12%

Other Operating Expenses, Total

aa.aa

8.05

8.07

8.32

7.73

8.37

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+22.69%	+0.29%	+3.1%	-7.14%	+8.32%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	7.37	7.91	6.99	7.76	7.31
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	0.68	0.16	1.34	-0.03	1.06

Operating Income

aa.aa

-23.7

-29.9

-30.01

-35.66

-35.06

Operating Income Growth

aa.aa

+2.63%

-26.18%

-0.38%

-18.8%

+1.67%

EBIT Margin %

aa.aa

-137.45%

-289.04%

-379.9%

-561.23%

-486.26%

Net Interest Expenses

aa.aa

0.33

1.67

7.91

0.91

-0.74

Net Interest Expenses Growth

aa.aa

+117.87%

+400.3%

+373.19%

-88.54%

-181.46%

Interest Expense, Total

aa.aa

-0.46

-0.8

-0.17

-1.68

-1.31

Interest And Investment Income

aa.aa

0.8

2.48

8.08

2.59

0.57

Other Non Operating Expenses, Total

aa.aa

0.04

-18.92

-0.19

0.78

-1.73

EBT, Excl. Unusual Items

aa.aa

-23.32

-47.14

-22.29

-33.97

-37.52

Gain (Loss) On Sale Of Assets

aa.aa

-0

-0.01

-0.04

-0

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

-19.54

-32.8

-22.33

-33.97

-37.52

EBT, Incl. Unusual Items Growth

aa.aa

-13.38%

-67.92%

+31.94%

-52.15%

-10.46%

EBT, Incl. Unusual Items Margin

aa.aa

-113.32%

-317.13%

-282.63%

-534.72%

-520.44%

Income Tax Expense

aa.aa

Net Income to Company

aa.aa

-19.54

-32.8

-22.33

-33.97

-37.52

Minority Interest

aa.aa

Net Income

aa.aa

-19.54

-32.8

-22.33

-33.97

-37.52

Net Income Growth

aa.aa

-13.38%

-67.92%

+31.94%

-52.15%

-10.46%

Net Income Margin %

aa.aa

-113.32%

-317.13%

-282.63%

-534.72%

-520.44%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-19.54

-32.8

-22.33

-33.97

-37.52

Basic EPS - Continuing Operations

aa.aa

-0.21

-0.33

-0.22

-0.29

-0.26

Basic EPS - Continuing Operations Growth

aa.aa

-2.1%

-53.76%

+32.67%

-31.18%

+10.84%

Diluted EPS - Continuing Operations

aa.aa

-0.21

-0.33

-0.22

-0.29

-0.26

Diluted EPS - Continuing Operations Growth

aa.aa

-2.1%

-53.9%

+32.74%

-31.18%

+10.71%

Basic Weighted Average Shares Outstanding

aa.aa

91.11

99.5

100.59

116.67

144.53

Diluted Weighted Average Shares Outstanding

aa.aa

91.11

99.5

100.59

116.67

144.53

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

-21.24

-28.21

-28.44

-34.37

-33.73

EBITDA Growth

aa.aa

+6.17%

-32.81%

-0.81%

-20.86%

+1.86%

EBITDA Margin %

aa.aa

-123.22%

-272.74%

-360%

-541.07%

-467.86%

EBIT

aa.aa

-23.7

-29.9

-30.01

-35.66

-35.06

* In Millions of EUR (except for per share items)

FAQ

What was Transgene’s revenue at year end?

At the end of the last reported fiscal year, Transgene (TRNG) recorded total revenue of 7.210 million EUR.

How much revenue did Transgene report in the most recent quarter?

In its most recent quarterly earnings report, Transgene posted revenue of 2.631 million EUR.

What was Transgene’s net income for the year?

For the full year, Transgene reported net income of -37.524 million EUR.

How much net income did Transgene post in the last quarter?

In the most recent quarter, Transgene (TRNG) posted net income of -18.229 million EUR.

What was Transgene’s gross profit for the year?

Gross profit for the year was reported at -26.686 million EUR.

How much gross profit did Transgene generate last quarter?

Transgene recorded gross profit of -13.355 million EUR in its latest quarterly report.

What was Transgene’s annual operating income?

For the full year, Transgene (TRNG) reported operating income of -35.059 million EUR.

What was Transgene’s operating income last quarter?

Quarterly operating income was -17.999 million EUR.

What was Transgene’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -17.323 million EUR.

What was the quarter-over-quarter change in EBITDA for Transgene?

EBITDA changed by -5.564% million EUR compared to the last quarter.

How did Transgene’s revenue change compared to the previous quarter?

Revenue changed by -42.542% million EUR compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Transgene?

In the latest quarter, gross profit changed by -0.180% million EUR from the previous quarter.

S&P/TSX

33,318.39

-265.95

-0.79%

S&P/TSX 60

1,943.80

-15.19

-0.78%

US 30

48,724.80

-136.9

-0.28%

US 500

7,169.60

+33.5

+0.47%

S&P 500 VIX

18.81

+0.98

+5.50%

DAX

23,954.56

-63.70

-0.27%

Dollar Index

98.737

-0.083

-0.08%

Market Movers

Name	Last	Chg. %	Vol.
ARC Resources	31.97	+1.91%	16.45M
ARC Resources	31.95	+1.30%	12.76M
Enbridge	73.01	+0.55%	8.11M
Manulife Financial	52.26	-1.02%	7.97M
TC Energy	87.56	+1.59%	7.06M
Toronto Dominion Bank	142.93	-0.84%	5.46M
RBC	239.99	-1.30%	2.68M

Name	Last	Chg. %	Vol.
PeakBirch Logic	0.030	+500.00%	1.32K
Voltage Metals	0.01	+100.00%	272.74K
Irwin Naturals	0.30	+150.00%	3.24K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Navco Pharmaceuticals	0.010	+100.00%	5.00K
ePlay Digital	0.010	+100.00%	7.00K
Montfort Capital	0.0100	+100.00%	1.00K

Name	Last	Chg. %	Vol.
Nirvana Life Sciences	0.01	-75.00%	8.00K
Resource Centrix Holdings	1.50	-60.00%	600.00
Patriot Gold	0.07	-51.85%	1.00K
Patriot Gold	0.07	-51.85%	1.00K
Armada Mercantile Ltd	0.135	-51.79%	7.00K
Albert Labs International	0.005	-50.00%	1.00K
New Frontier Ventures	0.015	-50.00%	4.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	515.17	+4.45%	560.67K
Whitecap Resources	16.02	+2.30%	8.15M
Canadian Natural	64.63	+1.88%	6.04M
Air Canada	18.01	-0.17%	2.66M
Cenovus Energy Inc	39.37	+4.85%	7.93M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaa A Aaaaaaaa	5.15	+65.58%	8.53
Aaaaaaaaaaaaaa Aa	5.88	+56.25%	9.19
Aaaaaaaa Aaa	89.78	+53.66%	137.96
Aa Aaaaaaaaaaaaaa	10.49	+43.00%	15.00
Aa Aa A Aa	10.84	+42.37%	15.43
A A Aaaaaa A A	23.15	+41.90%	32.85
Aaa Aaaa A	3.63	+40.60%	5.10

Name	Last	Upside	Fair Value
Aaaaaaaa A Aaaaaaaa	5.15	+65.58%	8.53
Aaaaaaaaaaaaaa Aa	5.88	+56.25%	9.19
Aaaaaaaa Aaa	89.78	+53.66%	137.96
Aa Aaaaaaaaaaaaaa	10.49	+43.00%	15.00
Aa Aa A Aa	10.84	+42.37%	15.43
A A Aaaaaa A A	23.15	+41.90%	32.85
Aaa Aaaa A	3.63	+40.60%	5.10

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Transgene (TRNG)

TRNG Income Statement

FAQ

What was Transgene’s revenue at year end?

How much revenue did Transgene report in the most recent quarter?

What was Transgene’s net income for the year?

How much net income did Transgene post in the last quarter?

What was Transgene’s gross profit for the year?

How much gross profit did Transgene generate last quarter?

What was Transgene’s annual operating income?

What was Transgene’s operating income last quarter?

What was Transgene’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Transgene?

How did Transgene’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Transgene?

Trending Stocks